Lannett reported $110.14M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amerisourcebergen ABC:US USD 43.48B 323.64M
Ani Pharmaceuticals ANIP:US USD 81.63M 14.68M
Aurora Cannabis Inc ACB:CN CAD 185.11M 39.88M
Canopy Growth Corp WEED:CN CAD 542.4M 137.99M
Cardinal Health CAH:US USD 31.56B 1.01B
Corcept Therapeutics CORT:US USD 53.07M 4.01M
Depomed DEPO:US USD 92.3M 23.85M
Endo International Ordinary Shares ENDP:US USD 543.05M 638.62M
JAZZ PHA JAZZ:US USD 812.95M 107.51M
Knight Therapeutics Inc GUD:CN CAD 139.53M 13.5M
Lannett LCI:US USD 110.14M 5.2M
Ligand Pharmaceuticals LGND:US USD 135.24M 32.61M
Mckesson MCK:US USD 48.36B 1.16B
Nektar Therapeutics NKTR:US USD 83.99M 21M
Novartis NVS:US USD 28.16B 514M
Omeros OMER:US USD 39.51M 1.01M
Pacira Pharmaceuticals PCRX:US USD 131.53M 1.65M
Perrigo Ordinary Shares PRGO:US USD 1.02B 400K
Phibro Animal Health PAHC:US USD 172.5M 18.33M
Prestige Brands PBH:US USD 152.31M 3.04M
Supernus Pharmaceuticals SUPN:US USD 725.99M 9.55M
Teva Pharmaceutical TEVA:IT USD 11.53B 538M
Zoetis ZTS:US USD 2.88B 171M